PL3558376T3 - Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPD - Google Patents
Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPDInfo
- Publication number
- PL3558376T3 PL3558376T3 PL17837879T PL17837879T PL3558376T3 PL 3558376 T3 PL3558376 T3 PL 3558376T3 PL 17837879 T PL17837879 T PL 17837879T PL 17837879 T PL17837879 T PL 17837879T PL 3558376 T3 PL3558376 T3 PL 3558376T3
- Authority
- PL
- Poland
- Prior art keywords
- steroid
- treatment
- therapeutic combination
- pulmonary surfactant
- bpd
- Prior art date
Links
- 239000003580 lung surfactant Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0082—Lung surfactant, artificial mucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16206232 | 2016-12-22 | ||
| EP17837879.0A EP3558376B1 (en) | 2016-12-22 | 2017-12-19 | A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving bpd |
| PCT/EP2017/083643 WO2018115013A1 (en) | 2016-12-22 | 2017-12-19 | A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving bpd |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3558376T3 true PL3558376T3 (pl) | 2022-02-14 |
Family
ID=57614211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17837879T PL3558376T3 (pl) | 2016-12-22 | 2017-12-19 | Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPD |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10668110B2 (pl) |
| EP (1) | EP3558376B1 (pl) |
| JP (2) | JP7777392B2 (pl) |
| KR (1) | KR102470549B1 (pl) |
| CN (1) | CN110099695B (pl) |
| AU (1) | AU2017384467B2 (pl) |
| BR (1) | BR112019012922A2 (pl) |
| CA (1) | CA3043792A1 (pl) |
| ES (1) | ES2902578T3 (pl) |
| MX (1) | MX391151B (pl) |
| PL (1) | PL3558376T3 (pl) |
| RU (1) | RU2757902C2 (pl) |
| WO (1) | WO2018115013A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019012922A2 (pt) * | 2016-12-22 | 2019-12-10 | Chiesi Farm Spa | combinação de um surfactante pulmonar, uso de uma combinação de um surfactante pulmonar e kit |
| EP3784212A1 (en) * | 2018-04-23 | 2021-03-03 | Chiesi Farmaceutici S.p.A. | A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of bpd |
| EP3936054A1 (en) * | 2020-07-08 | 2022-01-12 | Assistance Publique - Hôpitaux de Paris | Method of prognosis of bronchopulmonary dysplasia in premature infants |
| US12440471B2 (en) * | 2021-07-30 | 2025-10-14 | Ayuvis Research, Inc. | Compositions and methods for the treatment of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260273A (en) | 1988-01-06 | 1993-11-09 | The Scripps Research Institute | Pulmonary surfactant protein and related polypeptide |
| US5164369A (en) | 1988-01-06 | 1992-11-17 | The Scripps Research Institute | Pulmonary surfactant protein and related polypeptide |
| DE4418936A1 (de) | 1994-05-31 | 1996-02-08 | Byk Gulden Lomberg Chem Fab | Polypeptid |
| DE4434629C1 (de) * | 1994-09-28 | 1996-06-27 | Byk Gulden Lomberg Chem Fab | Zusammensetzungen zur Behandlung von IRDS und ARDS |
| IT1308180B1 (it) | 1999-02-12 | 2001-12-07 | Chiesi Farma Spa | Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante |
| US20060040860A1 (en) * | 2004-06-17 | 2006-02-23 | Mario Ruediger | Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia |
| ES2380046T3 (es) * | 2005-01-06 | 2012-05-08 | Discovery Laboratories, Inc. | Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar |
| US20070225233A1 (en) | 2006-03-27 | 2007-09-27 | Tsu-Fuh Yeh | Reducing the risk of chronic lung disease in infants |
| WO2008011559A2 (en) | 2006-07-20 | 2008-01-24 | University Of Rochester | Synthetic lung surfactant and use thereof |
| US20080066739A1 (en) * | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
| EP1997502A1 (en) | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| US8048043B2 (en) | 2007-06-08 | 2011-11-01 | Chiesi Farmaceutici S. P. A. | Method of administration of a pulmonary surfactant |
| BRPI1008165B1 (pt) * | 2009-05-25 | 2020-02-27 | Chiesi Farmaceutici S.P.A. | Uma combinação terapêutica compreendendo um surfactante pulmonar e um esteróide |
| US8399406B2 (en) * | 2009-06-05 | 2013-03-19 | Chiesi Farmaceutici S.P.A. | Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) |
| CA2773490A1 (en) | 2009-09-08 | 2011-03-17 | Chiesi Farmaceutici S.P.A. | A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| US9815869B2 (en) | 2012-02-09 | 2017-11-14 | University Of Rochester | SP-B and SP-C peptides, synthetic lung surfactants, and use thereof |
| BR112015009486B1 (pt) * | 2012-11-21 | 2022-06-14 | Chiesi Farmaceutici S.P.A | Surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído |
| EP3653119A1 (en) | 2013-03-13 | 2020-05-20 | Ino Therapeutics LLC | Devices for monitoring oxygenation during treatment with delivery of nitric oxide |
| MX384453B (es) * | 2014-06-20 | 2025-03-14 | Mallinckrodt Hospital Products Ip Ltd | Métodos in vitro para identificar lactantes prematuros en riesgo de displasia broncopulmonar. |
| HK1247140A1 (zh) * | 2015-04-22 | 2018-09-21 | 奇斯药制品公司 | 用於药物有效地呼吸同步递送到肺部的方法和系统 |
| BR112019012922A2 (pt) * | 2016-12-22 | 2019-12-10 | Chiesi Farm Spa | combinação de um surfactante pulmonar, uso de uma combinação de um surfactante pulmonar e kit |
-
2017
- 2017-12-19 BR BR112019012922A patent/BR112019012922A2/pt not_active Application Discontinuation
- 2017-12-19 KR KR1020197017832A patent/KR102470549B1/ko active Active
- 2017-12-19 CN CN201780079355.6A patent/CN110099695B/zh active Active
- 2017-12-19 MX MX2019006263A patent/MX391151B/es unknown
- 2017-12-19 PL PL17837879T patent/PL3558376T3/pl unknown
- 2017-12-19 CA CA3043792A patent/CA3043792A1/en not_active Withdrawn
- 2017-12-19 RU RU2019121940A patent/RU2757902C2/ru active
- 2017-12-19 ES ES17837879T patent/ES2902578T3/es active Active
- 2017-12-19 AU AU2017384467A patent/AU2017384467B2/en active Active
- 2017-12-19 EP EP17837879.0A patent/EP3558376B1/en active Active
- 2017-12-19 WO PCT/EP2017/083643 patent/WO2018115013A1/en not_active Ceased
- 2017-12-19 JP JP2019534320A patent/JP7777392B2/ja active Active
- 2017-12-21 US US15/850,546 patent/US10668110B2/en active Active
-
2020
- 2020-04-22 US US16/855,489 patent/US20200246391A1/en not_active Abandoned
-
2021
- 2021-10-22 US US17/508,053 patent/US20220040239A1/en not_active Abandoned
-
2023
- 2023-06-07 JP JP2023093805A patent/JP2023113852A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10668110B2 (en) | 2020-06-02 |
| WO2018115013A1 (en) | 2018-06-28 |
| KR102470549B1 (ko) | 2022-11-25 |
| AU2017384467A1 (en) | 2019-05-30 |
| US20220040239A1 (en) | 2022-02-10 |
| US20200246391A1 (en) | 2020-08-06 |
| JP7777392B2 (ja) | 2025-11-28 |
| ES2902578T3 (es) | 2022-03-29 |
| BR112019012922A2 (pt) | 2019-12-10 |
| RU2019121940A (ru) | 2021-01-22 |
| CA3043792A1 (en) | 2018-06-28 |
| EP3558376B1 (en) | 2021-10-20 |
| MX2019006263A (es) | 2019-08-21 |
| CN110099695B (zh) | 2022-01-25 |
| RU2757902C2 (ru) | 2021-10-22 |
| RU2019121940A3 (pl) | 2021-03-31 |
| EP3558376A1 (en) | 2019-10-30 |
| MX391151B (es) | 2025-03-21 |
| JP2020502242A (ja) | 2020-01-23 |
| JP2023113852A (ja) | 2023-08-16 |
| CN110099695A (zh) | 2019-08-06 |
| US20180177832A1 (en) | 2018-06-28 |
| KR20190099422A (ko) | 2019-08-27 |
| AU2017384467B2 (en) | 2023-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277648A (en) | Medical microbiota for the treatment and/or prevention of food allergy | |
| IL258002A (en) | Cenicriviroc combination therapy for the treatment of fibrosis | |
| IL266596A (en) | Causes, uses and methods of treating synovialitis | |
| IL250960B (en) | Combined treatment of sinecriviroc for the treatment of leprosy | |
| IL271117B (en) | Diazabicyclic mutated imidazopyrimidines and their use in the treatment of respiratory disorders | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| GB201513461D0 (en) | Methods and devices for the production of decellularised tissue scaffolds | |
| IL290754A (en) | Use of pyridofidine to treat anxiety and depression | |
| IL275683A (en) | Administering pulses of inhaled nitrous oxide for the treatment of pulmonary hypertension | |
| IL260352B (en) | Methods and preparations for the treatment of neurological disease | |
| IL260771B1 (en) | Catheter closure solution and catheter closure treatment | |
| IL254142B (en) | Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent | |
| IL246431A0 (en) | Treatment with halogen for heart attack and ischemic injury | |
| PL3352745T3 (pl) | Połączenie dofetylidu i meksyletyny w zapobieganiu i leczeniu migotania przedsionków | |
| IL264950B1 (en) | Combined treatments for the treatment of malignant liver cell carcinoma | |
| IL248875A0 (en) | Combinations of formoterol and budesonide for the treatment of chronic obstructive pulmonary disease | |
| PL3558376T3 (pl) | Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPD | |
| GB201504387D0 (en) | Materials and methods for the treatment of vascular disease | |
| HUE067036T2 (hu) | 2-hidroxibenzilamin alkalmazása pulmonális magas vérnyomás kezelésében és megelõzésében | |
| HUE050456T2 (hu) | Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra | |
| GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
| HUE068538T2 (hu) | Profilaktikus és/vagy terápiás szer dementia esetén | |
| IL251135A (en) | A method for the synthesis of hydroxy-triglycerides and their use for disease prevention and treatment | |
| SG11201703330YA (en) | Iminosugars useful for the treatment of viral diseases | |
| IL272422A (en) | Methods for treating diseases of the meninges |